Literature DB >> 10074350

Assembly of an exceptionally stable RNA tertiary interface in a group I ribozyme.

E A Doherty1, D Herschlag, J A Doudna.   

Abstract

Group I intron RNAs contain a core of highly conserved helices flanked by peripheral domains that stabilize the core structure. In the Tetrahymena group I ribozyme, the P4, P5, and P6 helices of the core pack tightly against a three-helix subdomain called P5abc. Chemical footprinting and the crystal structure of the Tetrahymena intron P4-P6 domain revealed that tertiary interactions between these two parts of the domain create an extensive solvent-inaccessible interface. We have examined the formation and stability of this tertiary interface by providing the P5abc segment in trans to a Tetrahymena ribozyme construct that lacks P5abc (EDeltaP5abc). Equilibrium gel shift experiments show that the affinity of the P5abc and EDeltaP5abc RNAs is exceptionally strong, with a Kd of approximately 100 pM at 10 mM MgCl2 (at 37 degrees C). Chemical and enzymatic footprinting shows that the RNAs are substantially folded prior to assembly of the complex. Solvent accessibility mapping reveals that, in the absence of P5abc, the intron RNA maintains a nativelike fold but its active-site helices are not tightly packed. Upon binding of P5abc, the catalytic core becomes more tightly packed through indirect effects of the tertiary interface formation. This two-component system facilitates quantitative examination of individual tertiary contacts that stabilize the folded intron.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074350     DOI: 10.1021/bi982113p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Monitoring intermediate folding states of the td group I intron in vivo.

Authors:  Christina Waldsich; Benoît Masquida; Eric Westhof; Renée Schroeder
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

2.  Distinct sites of phosphorothioate substitution interfere with folding and splicing of the Anabaena group I intron.

Authors:  Andrej Lupták; Jennifer A Doudna
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

3.  Structural specificity conferred by a group I RNA peripheral element.

Authors:  Travis H Johnson; Pilar Tijerina; Amanda B Chadee; Daniel Herschlag; Rick Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

4.  Thermodynamics and kinetics of RNA tertiary structure formation in the junctionless hairpin ribozyme.

Authors:  Neil A White; Charles G Hoogstraten
Journal:  Biophys Chem       Date:  2017-07-08       Impact factor: 2.352

5.  Deletion of the P5abc peripheral element accelerates early and late folding steps of the Tetrahymena group I ribozyme.

Authors:  Rick Russell; Pilar Tijerina; Amanda B Chadee; Hari Bhaskaran
Journal:  Biochemistry       Date:  2007-04-10       Impact factor: 3.162

6.  Structure-function analysis from the outside in: long-range tertiary contacts in RNA exhibit distinct catalytic roles.

Authors:  Tara L Benz-Moy; Daniel Herschlag
Journal:  Biochemistry       Date:  2011-09-19       Impact factor: 3.162

Review 7.  Unwinding RNA's secrets: advances in the biology, physics, and modeling of complex RNAs.

Authors:  Vincent B Chu; Daniel Herschlag
Journal:  Curr Opin Struct Biol       Date:  2008-06       Impact factor: 6.809

8.  Nob1 binds the single-stranded cleavage site D at the 3'-end of 18S rRNA with its PIN domain.

Authors:  Allison C Lamanna; Katrin Karbstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-14       Impact factor: 11.205

9.  Direct measurement of tertiary contact cooperativity in RNA folding.

Authors:  Bernie D Sattin; Wei Zhao; Kevin Travers; Steven Chu; Daniel Herschlag
Journal:  J Am Chem Soc       Date:  2008-04-23       Impact factor: 15.419

10.  The roles of S1 RNA-binding domains in Rrp5's interactions with pre-rRNA.

Authors:  Crystal L Young; Katrin Karbstein
Journal:  RNA       Date:  2011-01-13       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.